276 related articles for article (PubMed ID: 16344854)
1. Influence of mirtazapine on plasma concentrations of neuroactive steroids in major depression and on 3alpha-hydroxysteroid dehydrogenase activity.
Schüle C; Romeo E; Uzunov DP; Eser D; di Michele F; Baghai TC; Pasini A; Schwarz M; Kempter H; Rupprecht R
Mol Psychiatry; 2006 Mar; 11(3):261-72. PubMed ID: 16344854
[TBL] [Abstract][Full Text] [Related]
2. Mirtazapine does not influence tetrahydrodeoxycorticosterone levels in depressed patients.
Schüle C; Baghai TC; di Michele F; Eser D; Pasini A; Romeo E; Rupprecht R
World J Biol Psychiatry; 2010 Mar; 11(2 Pt 2):308-13. PubMed ID: 20218794
[TBL] [Abstract][Full Text] [Related]
3. Effects of combination treatment with mood stabilizers and mirtazapine on plasma concentrations of neuroactive steroids in depressed patients.
Schüle C; Baghai TC; di Michele F; Eser D; Pasini A; Schwarz M; Rupprecht R; Romeo E
Psychoneuroendocrinology; 2007 Jul; 32(6):669-80. PubMed ID: 17560730
[TBL] [Abstract][Full Text] [Related]
4. Plasma concentrations of neuroactive steroids before and after electroconvulsive therapy in major depression.
Baghai TC; di Michele F; Schüle C; Eser D; Zwanzger P; Pasini A; Romeo E; Rupprecht R
Neuropsychopharmacology; 2005 Jun; 30(6):1181-6. PubMed ID: 15702138
[TBL] [Abstract][Full Text] [Related]
5. Neuroactive steroids in responders and nonresponders to sleep deprivation.
Schüle C; Di Michele F; Baghai T; Romeo E; Bernardi G; Zwanzger P; Padberg F; Pasini A; Rupprecht R
Ann N Y Acad Sci; 2004 Dec; 1032():216-23. PubMed ID: 15677414
[TBL] [Abstract][Full Text] [Related]
6. Plasma concentrations of neuroactive steroids before and after repetitive transcranial magnetic stimulation (rTMS) in major depression.
Padberg F; di Michele F; Zwanzger P; Romeo E; Bernardi G; Schüle C; Baghai TC; Ella R; Pasini A; Rupprecht R
Neuropsychopharmacology; 2002 Nov; 27(5):874-8. PubMed ID: 12431862
[TBL] [Abstract][Full Text] [Related]
7. Effects of mirtazapine on dehydroepiandrosterone-sulfate and cortisol plasma concentrations in depressed patients.
Schüle C; Baghai TC; Eser D; Schwarz M; Bondy B; Rupprecht R
J Psychiatr Res; 2009 Feb; 43(5):538-45. PubMed ID: 18706658
[TBL] [Abstract][Full Text] [Related]
8. Neuroactive steroids in affective disorders: target for novel antidepressant or anxiolytic drugs?
Schüle C; Eser D; Baghai TC; Nothdurfter C; Kessler JS; Rupprecht R
Neuroscience; 2011 Sep; 191():55-77. PubMed ID: 21439354
[TBL] [Abstract][Full Text] [Related]
9. Influence of sleep deprivation on neuroactive steroids in major depression.
Schüle C; di Michele F; Baghai T; Romeo E; Bernardi G; Zwanzger P; Padberg F; Pasini A; Rupprecht R
Neuropsychopharmacology; 2003 Mar; 28(3):577-81. PubMed ID: 12629540
[TBL] [Abstract][Full Text] [Related]
10. Prevention of the stress-induced increase in the concentration of neuroactive steroids in rat brain by long-term administration of mirtazapine but not of fluoxetine.
Serra M; Pisul MG; Dazzi L; Purdy RH; Biggio G
J Psychopharmacol; 2002 Jun; 16(2):133-8. PubMed ID: 12095071
[TBL] [Abstract][Full Text] [Related]
11. 3alpha-reduced neuroactive steroids and their precursors during pregnancy and the postpartum period.
Gilbert Evans SE; Ross LE; Sellers EM; Purdy RH; Romach MK
Gynecol Endocrinol; 2005 Nov; 21(5):268-79. PubMed ID: 16373246
[TBL] [Abstract][Full Text] [Related]
12. Neuroactive steroids in depression and anxiety disorders: clinical studies.
Eser D; Schüle C; Baghai TC; Romeo E; Rupprecht R
Neuroendocrinology; 2006; 84(4):244-54. PubMed ID: 17159334
[TBL] [Abstract][Full Text] [Related]
13. Androgen inactivation and steroid-converting enzyme expression in abdominal adipose tissue in men.
Blouin K; Richard C; Brochu G; Hould FS; Lebel S; Marceau S; Biron S; Luu-The V; Tchernof A
J Endocrinol; 2006 Dec; 191(3):637-49. PubMed ID: 17170221
[TBL] [Abstract][Full Text] [Related]
14. Neuroactive steroids as modulators of depression and anxiety.
Eser D; Romeo E; Baghai TC; di Michele F; Schüle C; Pasini A; Zwanzger P; Padberg F; Rupprecht R
Neuroscience; 2006; 138(3):1041-8. PubMed ID: 16310959
[TBL] [Abstract][Full Text] [Related]
15. Neuroactive steroids and affective disorders.
Eser D; Schüle C; Baghai TC; Romeo E; Uzunov DP; Rupprecht R
Pharmacol Biochem Behav; 2006 Aug; 84(4):656-66. PubMed ID: 16831459
[TBL] [Abstract][Full Text] [Related]
16. Pathogenesis of diabetic neuropathy--do hyperglycemia and aldose reductase inhibitors affect neuroactive steroid formation in the rat sciatic nerves?
Colciago A; Negri-Cesi P; Celotti F
Exp Clin Endocrinol Diabetes; 2002 Jan; 110(1):22-6. PubMed ID: 11835121
[TBL] [Abstract][Full Text] [Related]
17. Increased neuroactive steroid concentrations in women with bipolar disorder or major depressive disorder.
Hardoy MC; Serra M; Carta MG; Contu P; Pisu MG; Biggio G
J Clin Psychopharmacol; 2006 Aug; 26(4):379-84. PubMed ID: 16855455
[TBL] [Abstract][Full Text] [Related]
18. Cortisol metabolism in depressed patients and healthy controls.
Römer B; Lewicka S; Kopf D; Lederbogen F; Hamann B; Gilles M; Schilling C; Onken V; Frankhauser P; Deuschle M
Neuroendocrinology; 2009; 90(3):301-6. PubMed ID: 19713693
[TBL] [Abstract][Full Text] [Related]
19. Mirtazapine acutely inhibits salivary cortisol concentrations in depressed patients.
Laakmann G; Hennig J; Baghai T; Schüle C
Ann N Y Acad Sci; 2004 Dec; 1032():279-82. PubMed ID: 15677428
[TBL] [Abstract][Full Text] [Related]
20. Comparative non-radioactive RT-PCR assay: an approach to study the neurosteroids biosynthetic pathway in humans.
Luchetti S; di Michele F; Romeo E; Brusa L; Bernardi G; Cummings BJ; Longone P
J Neurosci Methods; 2006 Jun; 153(2):290-8. PubMed ID: 16378642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
